Related Experiment Videos

[Mechanisms of inflammation in heart failure]

Martin Fuchs1, Helmut Drexler

  • 1Abteilung Kardiologie und Angiologie, Zentrum Innere Medizin, Medizinische Hochschule Hannover.

Herz
|December 16, 2004
PubMed

Insights

Chronic heart failure involves myocardial dysfunction, neuroendocrine system activation, and inflammation, all contributing to disease progression. Targeting inflammation, like tumor necrosis factor-alpha, may not always improve outcomes in heart failure patients.

Area of Science:

  • Cardiology
  • Pathophysiology
  • Immunology

Context:

  • Chronic heart failure (CHF) was historically viewed as solely a myocardial issue.
  • Emerging evidence highlights the roles of neuroendocrine activation and inflammation in CHF pathogenesis.
  • Left ventricular remodeling is significantly influenced by inflammatory mechanisms.

Purpose:

  • To elucidate the multifaceted nature of chronic heart failure beyond myocardial contractility.
  • To explore the contribution of neuroendocrine and inflammatory pathways to CHF progression and prognosis.
  • To evaluate the clinical implications of targeting inflammatory mediators in heart failure.

Summary:

  • CHF pathophysiology involves impaired myocardial contractility, activated sympathetic nervous system, and renin-angiotensin-aldosterone system.
  • Inflammatory processes are implicated in left ventricular remodeling, contributing to symptoms and disease advancement.
  • Long-term detrimental effects of inflammation contrast with potential acute protective roles during ischemia; broad anti-inflammatory strategies may not be beneficial.

Impact:

  • Provides a comprehensive understanding of CHF as a complex syndrome involving cardiac, neuroendocrine, and inflammatory systems.
  • Suggests that therapeutic strategies targeting inflammation require careful consideration due to potential dual effects.
  • Informs future research directions and clinical trial design for heart failure management.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...